Contact Lipedema Surgical Solutions to schedule a consultation and explore how these innovative treatments can complement your care.
A recent meta-analysis of patients with HFrEF enrolled in the DAPA-HF and EMPEROR-Reduced trials demonstrated a 14% reduction in CV death and a 31% reduction in first hospitalisation for HF, whereas the composite outcome of CV death and HF hospitalisation was reduced by 25%, regardless of the presence or absence of T2D
Patients often consider NAD after they have stabilized on a GLP-1 medication but still want support for daily stamina, hydration, or workout recovery
The hard truth: While the skin may look and feel better to the touch, a topical serum cannot physically contract or remove excess skin
Alimentary Pharmacology & Therapeutics, 17 (4), 595-601
10.1111/acel.13328 Aging Cell 72 HaseenaP